Donor hematopoiesis or donor chimerism in the host following allogeneic bone marrow
transplantation (BMT) has appeared crucial to the engraftment process. However, as …

Using in situ hybridization with an X and Y chromosome probe mixture, 106 bone marrow
samples from 38 patients with malignant and non-malignant hematological diseases who …

In this study we analysed the incidence and clinical impact of the persistence of host
haemopoiesis (mixed chimaerism, MC) after allogeneic BMT in 35 consecutive patients with …

In the light of reduced intensity conditioning regimens for allogeneic transplantation,
monitoring of donor cell engraftment acquires new relevance. We analysed the clinical …

Mixed hematopoietic chimerism (MC) is a common finding after allogeneic bone marrow
transplantation (BMT), but the natural history of this phenomenon remains unclear. To …

Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia
patients after allogeneic hematopoietic stem cell transplantation | Leukemia Skip to main …

Abstract Twenty-nine of 172 patients (17%) who received an allogeneic bone marrow
transplant (BMT) from histocompatible sibling donors for hematologic malignancies were …

The monitoring of chimerism has become a routine diagnostic instrument at centers
performing allogeneic stem cell or bone marrow transplantation. Despite the widespread …

Determination of donor chimerism profiles in blood or bone marrow from patients with
allogeneic stem cell transplantation (SCT) is useful for monitoring engraftment or predicting …

We recently reported that virtually all children with acute leukaemia and myelodysplastic
syndrome (MDS) who develop the phenotype of increasing mixed chimaerism (MC) after …